Published on: July 12, 2019 at 09:30PM
Conditions: Diabetes Mellitus, Type 2; Urosepsis; Diabetic Ketoacidosis; Lower Extremity Amputation
Interventions: Drug: Sodium-glucose cotransporter 2 (SGLT2) inhibitors; Drug: Dipeptidyl peptidase-4 (DPP-4) inhibitors; Drug: Other treatment combinations
Sponsors: Canadian Network for Observational Drug Effect Studies, CNODES; Drug Safety and Effectiveness Network, Canada; Canadian Institutes of Health Research (CIHR)
Active, not recruiting
https://ift.tt/32qY6xJ
Friday, 12 July 2019
New diabetes clinical trial: Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.